IPPRA / Grant Monitor

2026-07-07
← Board

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

PAR-25-081 · National Institutes of Health

biomedical clinical public health computing communications ai data science Education Health

Closes
2027-01-07 · 184 d
Award ceiling
$499,999
Award floor
Program funding
$499,999
Expected awards
Cost sharing
No
Posted
2024-11-12
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-07-07

NCI funds investigator-initiated early phase cancer clinical trials of diagnostic or therapeutic interventions for eligible organizations, including U.S. universities.

Funds
basic research
University
direct
social behavioral
minor
physical sciences
minor
engineering
minor
life biomedical
central
computational data
minor

⚑ Clinical trial required; early phase only (Phase 0, I, II). · Budget ceiling is $499,999. · Targets NCI DCTD/OHAM program areas (e.g., cancer therapy, imaging, diagnosis, radiation, CAM, HIV/AIDS malignancies). · Foreign organizations are eligible under this notice.

Unit fits — one characterization, each unit's own rules

Physical Sciences & Engineering (demo) 65 good technical depth: minor; funds basic research
IPPRA 58 good peripheral portfolio topic: public_health; social/behavioral work is minor; funds basic research; biomedical core — IPPRA health lane is communication/crisis/policy (capped); clinical-trial/biomedical core — IPPRA angle is policy/community (capped)
Tom Love Innovation Hub 15 none deep-tech content; no commercialization signal

Description

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Apply

View on Grants.gov → CONTACT: National Institutes of Health <grantsinfo@nih.gov>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · National Institutes of Health conventions SEE AN NIH EXAMPLE →

Funder-faithful document skeletons — National Institutes of Health's document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING